FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206754963> ?p ?o ?g. }

• W4206754963 endingPage "52" @default.
• W4206754963 startingPage "43" @default.
• W4206754963 abstract "Moxonidine is a centrally acting, anti-hypertensive medication that exerts additional metabolic properties. It is unknown whether its effects are mediated by neurotransmitters or sympathetic tone regulators, including Neuropeptide Y (NPY). In this study, we evaluated the effects of moxonidine administration on serum NPY in humans. Methods: Ninety individuals with mild or moderate arterial hypertension that required monotherapy were categorized in three age and gender-matched groups according to their Body Mass Index (BMI) as normal weight (n = 30), overweight (n = 30), and obese (n = 30). Moxonidine was administered in therapeutic doses of up to 0.6 mg daily for 12 weeks, and clinical, biochemical and hormonal parameters were recorded. Results: In all three groups, a decrease in systolic and diastolic blood pressure and heart rate was shown. After treatment, BMI, 24 h urine catecholamines and catecholamines’ metabolites, and serum total cholesterol were also reduced. Most importantly, we found a decrease in serum NPY levels in all study groups, with the largest mean decrease in the group of obese and overweight participants compared to normal weight. Conclusions: Moxonidine administration results in improvement in cardio-metabolic parameters, as well as a decrease in serum NPY levels, which therefore represents it being a potent agent against obesity-associated hypertension. Its involvement in energy balance regulation warrants further investigation." @default.
• W4206754963 created "2022-01-26" @default.
• W4206754963 creator A5000659889 @default.
• W4206754963 creator A5004790580 @default.
• W4206754963 creator A5012739379 @default.
• W4206754963 creator A5018642930 @default.
• W4206754963 creator A5026506222 @default.
• W4206754963 creator A5027197073 @default.
• W4206754963 creator A5034510351 @default.
• W4206754963 creator A5055184572 @default.
• W4206754963 creator A5055934498 @default.
• W4206754963 creator A5070394856 @default.
• W4206754963 date "2022-01-12" @default.
• W4206754963 modified "2023-09-25" @default.
• W4206754963 title "Effects of Moxonidine Administration on Serum Neuropeptide Y Levels in Hypertensive Individuals: A Prospective Observational Study" @default.
• W4206754963 cites W1496108278 @default.
• W4206754963 cites W1576880551 @default.
• W4206754963 cites W1972801970 @default.
• W4206754963 cites W1992609447 @default.
• W4206754963 cites W1993726729 @default.
• W4206754963 cites W1995184482 @default.
• W4206754963 cites W1999704561 @default.
• W4206754963 cites W2002941555 @default.
• W4206754963 cites W2004992608 @default.
• W4206754963 cites W2007023336 @default.
• W4206754963 cites W2010072332 @default.
• W4206754963 cites W2013833037 @default.
• W4206754963 cites W2017431575 @default.
• W4206754963 cites W2019010829 @default.
• W4206754963 cites W2041215629 @default.
• W4206754963 cites W2041353973 @default.
• W4206754963 cites W2041453294 @default.
• W4206754963 cites W2060856904 @default.
• W4206754963 cites W2074597875 @default.
• W4206754963 cites W2088257585 @default.
• W4206754963 cites W2124653803 @default.
• W4206754963 cites W2126619119 @default.
• W4206754963 cites W2133416234 @default.
• W4206754963 cites W2142204138 @default.
• W4206754963 cites W2148841524 @default.
• W4206754963 cites W2150789600 @default.
• W4206754963 cites W2164644545 @default.
• W4206754963 cites W2167113560 @default.
• W4206754963 cites W2303651371 @default.
• W4206754963 cites W2462200989 @default.
• W4206754963 cites W2767794065 @default.
• W4206754963 doi "https://doi.org/10.3390/endocrines3010004" @default.
• W4206754963 hasPublicationYear "2022" @default.
• W4206754963 type Work @default.
• W4206754963 citedByCount "2" @default.
• W4206754963 countsByYear W42067549632022 @default.
• W4206754963 countsByYear W42067549632023 @default.
• W4206754963 crossrefType "journal-article" @default.
• W4206754963 hasAuthorship W4206754963A5000659889 @default.
• W4206754963 hasAuthorship W4206754963A5004790580 @default.
• W4206754963 hasAuthorship W4206754963A5012739379 @default.
• W4206754963 hasAuthorship W4206754963A5018642930 @default.
• W4206754963 hasAuthorship W4206754963A5026506222 @default.
• W4206754963 hasAuthorship W4206754963A5027197073 @default.
• W4206754963 hasAuthorship W4206754963A5034510351 @default.
• W4206754963 hasAuthorship W4206754963A5055184572 @default.
• W4206754963 hasAuthorship W4206754963A5055934498 @default.
• W4206754963 hasAuthorship W4206754963A5070394856 @default.
• W4206754963 hasBestOaLocation W42067549631 @default.
• W4206754963 hasConcept C118303440 @default.
• W4206754963 hasConcept C126322002 @default.
• W4206754963 hasConcept C134018914 @default.
• W4206754963 hasConcept C170493617 @default.
• W4206754963 hasConcept C2777014715 @default.
• W4206754963 hasConcept C2778938600 @default.
• W4206754963 hasConcept C2780221984 @default.
• W4206754963 hasConcept C2780578515 @default.
• W4206754963 hasConcept C2780586474 @default.
• W4206754963 hasConcept C511355011 @default.
• W4206754963 hasConcept C71924100 @default.
• W4206754963 hasConcept C84393581 @default.
• W4206754963 hasConcept C93984277 @default.
• W4206754963 hasConceptScore W4206754963C118303440 @default.
• W4206754963 hasConceptScore W4206754963C126322002 @default.
• W4206754963 hasConceptScore W4206754963C134018914 @default.
• W4206754963 hasConceptScore W4206754963C170493617 @default.
• W4206754963 hasConceptScore W4206754963C2777014715 @default.
• W4206754963 hasConceptScore W4206754963C2778938600 @default.
• W4206754963 hasConceptScore W4206754963C2780221984 @default.
• W4206754963 hasConceptScore W4206754963C2780578515 @default.
• W4206754963 hasConceptScore W4206754963C2780586474 @default.
• W4206754963 hasConceptScore W4206754963C511355011 @default.
• W4206754963 hasConceptScore W4206754963C71924100 @default.
• W4206754963 hasConceptScore W4206754963C84393581 @default.
• W4206754963 hasConceptScore W4206754963C93984277 @default.
• W4206754963 hasIssue "1" @default.
• W4206754963 hasLocation W42067549631 @default.
• W4206754963 hasOpenAccess W4206754963 @default.
• W4206754963 hasPrimaryLocation W42067549631 @default.
• W4206754963 hasRelatedWork W1903601530 @default.
• W4206754963 hasRelatedWork W1965857465 @default.
• W4206754963 hasRelatedWork W1970225575 @default.
• W4206754963 hasRelatedWork W1995926452 @default.

• next